Our site uses cookies necessary for its proper functioning. To improve your experience, other cookies may be used: you can choose to disable them. This can be changed at any time via the Cookies link at the bottom of the page.

Université de Bordeaux
 

Zuzana Koŝutzká, Ph.D.

Last update Wednesday 08 September 2021

Comenius University in Bratislava, Slovakia

Zuzana Koŝutzká, Ph.D.

Zuzana KOŠUTZKÁ, M.D., Ph.D., completed neurological clinical training at Comenius University, Bratislava, Slovakia. Currently, she works as a movement disorder specialist in 2nd Department of Neurology in Bratislava, Slovakia. She is the head of the neuromodulation section managing patients with deep brain stimulation and scientific coordinator of the department. Her expertise is also guided application of botulinum toxin in neurological disorders.

In 2018, she completed her Ph.D. that was dedicated to gait and balance problems in Parkinson's disease. During the Ph.D. she worked as an Honorary Research Associate in the Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Faculty of Brain Sciences, UCL, London, UK (Supervisor: Prof. Patricia Limousin, Prof. Brian Day 2013-2015). In 2017, she was awarded a one-year post-doc scholarship in the Brain and Spine Institute, Salpetriere Hospital in Paris supervised by Prof. Marie Vidailhet. The research project was focused on the management of deep brain stimulation patients with rare diseases and stimulation-induced gait problems.

Her current research interest is in movement disorders. With her team, she is studying the effects of dopaminergic treatment on impulsive beahviour by the means of eye tracking. With the cooperation of the electric engineering faculty, she is developing new software for objective assessment of bradykinesia and gait. Her epidemiological research is dedicated to the prevalence, risk factors and consequences of falls on the Slovak population. She is also the CEO of a software company developing digital biomarkers (motion, cognition, speech) of brain disorders.